Done sou Salè H1B

Akèy › Anplwayè › Intellia Therapeutics › Principal Scientist

Principal Scientist nan Intellia Therapeutics: Salè H-1B

7 aplikasyon kondisyon travay pou tit travay Principal Scientist nan Intellia Therapeutics. Salè baz medyàn ofri $162,750; mwatye mitan $160,000–$170,625.

Demann (LCA)7
Salè medyan ofri$162,750
Mwatye salè yo$160,000–$170,625
10yèm–90yèm pousantaj$158,600–$172,100

Pa ane fiskal

Ane fiskalLCASalè medyan
FY20235$161,000
FY20241$172,100
FY20251$172,100

Aplikasyon

Salè bazKoteSoumètDat kòmansmanEstati
$172,100
Nivo IV
Cambridge, MAFeb 21, 2025Aug 22, 2025Certifye
$172,100
Nivo IV
Cambridge, MAMar 12, 2024Aug 30, 2024Certifye
$161,000
Nivo IV
Cambridge, MAAug 31, 2023Feb 1, 2024Certifye
$162,750
Nivo IV
Cambridge, MAMar 14, 2023Aug 12, 2023Certifye
$159,000
Nivo IV
Cambridge, MAMar 8, 2023Aug 12, 2023Certifye
$169,150
Nivo IV
Cambridge, MAMar 1, 2023Aug 30, 2023Certifye
$158,000
Nivo IV
Cambridge, MADec 8, 2022Dec 15, 2022Certifye

Principal Scientist nan tout anplwayè yo →

Lòt travay nan Intellia Therapeutics

Salè yo se fen ki pi ba nan salè yo ofri sou chak aplikasyon, konvèti nan yon montan anyèl; estatistik yo itilize sèlman aplikasyon tan plen sètifye. Yon LCA pa yon apwobasyon visa epi yon sèl LCA ka kouvri plizyè pozisyon. Sous: Depatman Travay Etazini, Done Divulgasyon LCA OFLC, ane fiskal 2023–2026 (dènye desizyon Jun 30, 2026).